8/26/2010

U.S. District Judge Emmet Sullivan denied a request by Sanofi-Aventis to prevent an FDA-approved copy of its blood thinner Lovenox from going into the market. The generic was developed by Novartis' Sandoz subsidiary and Momenta Pharmaceuticals. The judge said delaying the distribution of the generic could have a negative effect on the public.

Related Summaries